Logopharm

Logopharm provides specialized services in proteomic target and biomarker R&D with a strong focus on membrane proteins, protein complexes and antibody validation. Founded in 2005 as a spinout of the University of Freiburg, Germany, the company combines most advanced technology and instrumentation with long-term experience in membrane protein analysis and molecular physiology to tackle even the most challenging targets, like ion channels, G-protein coupled receptors or other membrane receptors and transporters. Molecular characterization of these targets delivers relevant information for drug development, such as post-translational modifications, subunit composition, interaction partners or changes in abundance.